473 related articles for article (PubMed ID: 31066492)
1. Excellent response to mesotherapy as adjunctive treatment in male androgenetic alopecia.
Melo DF; de Mattos Barreto T; Plata GT; Araujo LR; Tortelly VD
J Cosmet Dermatol; 2020 Jan; 19(1):75-77. PubMed ID: 31066492
[TBL] [Abstract][Full Text] [Related]
2. Frontal edema due to mesotherapy for androgenetic alopecia: A case series.
Melo DF; Saceda-Corralo D; Tosti A; Weffort F; Carla Jorge M; de Barros CC; de Melo Carvalho R; Starace M
Dermatol Ther; 2022 Feb; 35(2):e15247. PubMed ID: 34877759
[TBL] [Abstract][Full Text] [Related]
3. Controversies in the treatment of androgenetic alopecia: The history of finasteride.
Andy G; John M; Mirna S; Rachita D; Michael K; Maja K; Aseem S; Zeljana B
Dermatol Ther; 2019 Mar; 32(2):e12647. PubMed ID: 30253001
[TBL] [Abstract][Full Text] [Related]
4. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
[TBL] [Abstract][Full Text] [Related]
5. Androgenetic alopecia: an evidence-based treatment update.
Varothai S; Bergfeld WF
Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
[TBL] [Abstract][Full Text] [Related]
6. A review of the treatment of male pattern hair loss.
York K; Meah N; Bhoyrul B; Sinclair R
Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
[No Abstract] [Full Text] [Related]
7. What's New in Therapy for Male Androgenetic Alopecia?
Saceda-Corralo D; Domínguez-Santas M; Vañó-Galván S; Grimalt R
Am J Clin Dermatol; 2023 Jan; 24(1):15-24. PubMed ID: 36169916
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of various treatment regimens for androgenetic alopecia in men.
Khandpur S; Suman M; Reddy BS
J Dermatol; 2002 Aug; 29(8):489-98. PubMed ID: 12227482
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients.
Hu R; Xu F; Sheng Y; Qi S; Han Y; Miao Y; Rui W; Yang Q
Dermatol Ther; 2015; 28(5):303-8. PubMed ID: 26031764
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.
Tanglertsampan C
J Med Assoc Thai; 2012 Oct; 95(10):1312-6. PubMed ID: 23193746
[TBL] [Abstract][Full Text] [Related]
11. Comparing the Efficacy of Mesotherapy to Topical Minoxidil in the Treatment of Female Pattern Hair Loss Using Ultrasound Biomicroscopy: A Randomized Controlled Trial.
Hunter N; Sayed K; Hay RA; Allam R; Hussein N
Acta Dermatovenerol Croat; 2019 Mar; 27(1):1-7. PubMed ID: 31032783
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: A blinded randomized clinical trial.
Sadeghzadeh Bazargan A; Tavana Z; Dehghani A; Jafarzadeh A; Tabavar A; Alavi Rad E; Goodarzi A
J Cosmet Dermatol; 2024 Feb; 23(2):543-551. PubMed ID: 37650533
[TBL] [Abstract][Full Text] [Related]
13. Multi-therapies in androgenetic alopecia: review and clinical experiences.
Rossi A; Anzalone A; Fortuna MC; Caro G; Garelli V; Pranteda G; Carlesimo M
Dermatol Ther; 2016 Nov; 29(6):424-432. PubMed ID: 27424565
[TBL] [Abstract][Full Text] [Related]
14. Mesotherapy as a Promising Alternative to Minoxidil for Androgenetic Alopecia: A Systematic Review.
Aledani EM; Kaur H; Kasapoglu M; Yadavalli R; Nawaz S; Althwanay A; Nath TS
Cureus; 2024 May; 16(5):e59705. PubMed ID: 38841017
[TBL] [Abstract][Full Text] [Related]
15. Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil
Gentile P; Garcovich S
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32295047
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of low-dose oral minoxidil in the management of androgenetic alopecia.
Gupta AK; Talukder M; Shemer A
Expert Opin Pharmacother; 2024 Feb; 25(2):139-147. PubMed ID: 38315101
[TBL] [Abstract][Full Text] [Related]
17. Prescribing Habits for Androgenic Alopecia Among Dermatologists in Spain in 2017: A Cross-Sectional Study.
Pindado-Ortega C; Saceda-Corralo D; Buendía-Castaño D; Fernández-González P; Moreno-Arrones ÓM; Fonda-Pascual P; Alegre-Sánchez A; Rodrigues-Barata AR; Vañó-Galván S
Actas Dermosifiliogr (Engl Ed); 2018; 109(6):536-542. PubMed ID: 29656764
[TBL] [Abstract][Full Text] [Related]
18. Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo-controlled trial.
Uzel BPC; Takano GHS; Chartuni JCN; Cesetti MV; Gavioli CFB; Lemes AM; Costa IMC
Dermatol Ther; 2021 Jan; 34(1):e14622. PubMed ID: 33269529
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
[TBL] [Abstract][Full Text] [Related]
20. Physiology and Medical Treatments for Alopecia.
Tai T; Kochhar A
Facial Plast Surg Clin North Am; 2020 May; 28(2):149-159. PubMed ID: 32312501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
